Varicella epidemiology in Latin America and the Caribbean

Ávila-Agüero, María Luisa; Beltrán, Sandra; Castillo, José Brea del; Díaz, María Esther Castillo; Chaparro, Luis Eduardo; Deseda, Carmen; Debbag, Roberto; Espinal, Carlos; Falleiros-Arlant, Luiza Helena; Mata, Antonio José González; Parra, Mercedes Macías; Marques-Rosa, Fabiano; Pírez, María Catalina; Vázquez-Rivera, Mirella

doi:10.1080/14760584.2018.1418327

Cited by 14 publications

(19 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Among other gray literature, SLIPE in 2016 [10, 18, 52] reported incidence rates of 147/100,000 in Venezuela, 148/100,000 in Uruguay, 213/100,000 in Colombia, and 393/100,000 in Argentina. Barbados recorded 1345 reported cases in a population of 270,000 for the 2008–2010 period, and Jamaica recorded 2646 cases of varicella in a population 2.7 million in 2010 [53, 54].…”

Section: Resultsmentioning

confidence: 99%

“…In Puerto Rico, there has been a substantial decrease in the morbidity associated with varicella following the introduction of vaccination – from 11.6 cases/100,000 in 1998 to 2.8 cases/100,000 in 2015 (Departamento de Salud, Puerto Rico, cited by Avila-Aguero et al) [10].…”

Section: Resultsmentioning

confidence: 99%

“…Latin America and the Caribbean (LAC) is a diverse region of mainly middle-income countries, mostly located within the tropics. Compared with the United States and other high-income, temperate countries, the data on varicella epidemiology in LAC are scarce [10, 11].…”

Section: Introductionmentioning

confidence: 99%

“…The World Health Organization recommends that countries with a substantial public health burden of varicella should consider incorporating vaccination within the routine childhood immunization program, provided resources can support ≥ 80% coverage [4]. In 2016, the Latin American Society of Pediatric Infectious Diseases (Sociedad Latinoamericana de Infectologia Pediátrica [SLIPE]) recommended the inclusion of two-dose varicella vaccination within the national immunization schedules of all LAC countries [10, 18]. As of January 2018, 14 (out of 35) countries had implemented universal varicella vaccination (UVV), including six with a two-dose schedule [19] (Table 1 and Fig.…”

Section: Introductionmentioning

confidence: 99%

“…Other countries have targeted publicly funded vaccination to at-risk groups instead of adopting universal vaccination. For example, in Mexico, publicly funded vaccination is provided to children attending child development centers, people with immunodeficiency, children with cancer, and certain susceptible healthcare workers (HCWs) [10].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review

et al. 2019

View full text Add to dashboard Cite

Background Varicella is typically mild and self-limiting, but can be associated with complications and even death. The limited data available on varicella in Latin America and the Caribbean (LAC) indicate substantial burden in countries where varicella vaccine is not part of publicly funded childhood national immunization programs. Methods A systematic literature review of published studies was complemented by “gray” literature on varicella incidence, complications, mortality, and economic consequences, in the absence and presence of universal varicella vaccination (UVV) in LAC. Results Seroprevalence data indicate that varicella is usually a disease of childhood in LAC. Varicella incidence rates, while unreliable in the absence of mandatory reporting, show a trend to increased incidence due to greater urbanization and population density. The introduction of UVV in national immunization programs has led to significant reductions in varicella incidence in these areas. Conclusions Varicella continues to pose a substantial healthcare burden in LAC. The future introduction of UVV in additional countries is predicted to provide substantial reductions in cases, with important economic benefits. For countries that have already implemented UVV, the challenge is to maintain high rates of coverage and, where relevant, consider inclusion of a second dose to reduce breakthrough cases. Given the significant proportion of the region now implementing UVV, a regional recommendation in order to prevent any potential for age-shifts in varicella infection might be considered. Electronic supplementary material The online version of this article (10.1186/s12889-019-6795-0) contains supplementary material, which is available to authorized users.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review

et al. 2019

View full text Add to dashboard Cite

show abstract

Political, Social, and Economic Crises in Public Communication

Imhof¹

2016

The Handbook of International Crisis Communication Research

View full text Add to dashboard Cite

During the last months, there has been a significant increase in the evidence showing the catastrophic health situation in Venezuela. There are multiple epidemics, increase in emerging and reemerging infectious, tropical and parasitic diseases as consequences of the social, economic and political crises, which would be considered today an anthropogenic disaster. Venezuela is facing in 2019, the worse sanitary conditions, with multiple implications for public health and travel medicine. So far, from a global perspective, this situation will be an impediment for the achievement of sustainable development goals (SDG) in 2030. In this multiauthor review, there is a comprehensive analysis of the situation for infectious diseases, non-communicable diseases, their impact in the Americas region, given the migration crisis as well as the relative status of the SDG 2030. This discussion can provide input for prioritizing emerging health problems and establish a future agenda.

show abstract

Herpesvirus-Associated Encephalitis: an Update

et al. 2022

View full text Add to dashboard Cite

Purpose of Review Herpesviruses are a leading cause of encephalitis worldwide. The article reviews the eight human herpesviruses with a focus on recent advances as they pertain to encephalitis. Recent Findings Notable recent updates include the development of multiplex polymerase chain reaction (PCR)-based panels, which have improved access to PCR tests, especially in rural and resource-limited areas. Despite unchanged treatment recommendations, research is ongoing into novel therapies. There have been recent advances in vaccines, particularly for varicella zoster virus (VZV) which may impact neurologic complications. Finally, the recent discovery of an association between herpes encephalitis and post-infectious autoimmune encephalitis has had a critical impact on the fields of infectious and autoimmune neurology, though there remains much to learn. Summary Most herpesviruses are neurotropic and must be considered on the differential diagnosis for infectious encephalitis. This article describes recent advances in the diagnosis, treatment, complications, and management of these infections.

show abstract

Varicella epidemiology in Latin America and the Caribbean

Cited by 14 publications

References 0 publications

Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review

Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review

Political, Social, and Economic Crises in Public Communication

Herpesvirus-Associated Encephalitis: an Update

Contact Info

Product

Resources

About